Researchers report a link between use of glitazones to treat type 2 diabetes and a 22% reduced risk of dementia. The findings appeared on Oct 11, 2022 in BMJ Open Diabetes Research & Care. “These findings may help inform medication selection for [older] patients with [type 2 diabetes] at high risk of dementia,” the authors said. As background, the authors noted […]
Drinking a small amount of whey protein before meals has been shown to help people with type 2 diabetes control their blood sugars. In a study, which holds potential for dietary management of the condition, people with type 2 diabetes drank a pre-made shot before meals which contained a low dose of whey protein. They were monitored for a week […]
Reproductive hormone levels in females with obesity may be partially restored by lowering blood glucose levels, leading to improved fertility, according to a study published in the Journal of Endocrinology. The study indicates that altered levels of reproductive hormones in a well-established mouse model of obesity may be partially restored by a common type 2 diabetes medication that reduces blood glucose […]
The European Commission has granted marketing authorization in the European Union (EU) for finerenone under the brand name Kerendia from Bayer HealthCare. Kerendia (10 mg or 20 mg), a non-steroidal, selective mineralocorticoid receptor antagonist, is indicated for the treatment of chronic kidney disease (stage 3 and 4 with albuminuria) associated with type 2 diabetes in adults. “Even when blood glucose […]
Women with long or irregular periods are known to have a higher risk of type 2 diabetes and heart disease, but researchers found these women may also be at risk for nonalcoholic fatty liver disease (NAFLD), according to a new study published in the Endocrine Society’s Journal of Clinical Endocrinology and Metabolism. About 24% of U.S. adults have NAFLD, a chronic […]
Researchers report that patients diagnosed with type 2 diabetes in their youth are, by young adulthood, at risk of serious complications. The findings from the TODAY2 study (Treatment Options for type 2 Diabetes in Adolescents and Youth) appeared in the NEJM/New England Journal of Medicine on July 28, 2021. “Youth-onset of type 2 diabetes is associated with an accumulation of diabetes-related complications […]
Article by Bruce Sylvester. Patients diagnosed with type 2 diabetes and treated with weekly semaglutide have achieved an average weight loss of almost 10kg, researchers reported on March 2, 2021 in The Lancet. Put in other terms, two-thirds of subjects treated with weekly injections of a 2.4mg semaglutide lost at least 5% of their body weight and achieved significant improvement in […]
Recent Comments